Clinical Trial Update: A Study of JNJ-87890387 for Advanced Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 study of JNJ-87890387 for advanced solid tumors is currently recruiting, evaluating safety and preliminary efficacy in cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• JNJ-87890387

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Neoplasms, Advanced Solid Tumors | Phase 1 | Status: RECRUITING